Liposomal bupivacaine for the management of postsurgical donor site pain in patients with burn injuries: a case series from two institutions

Sharmila Dissanaike, Jayne McCauley, Carlo Alphonso, Sharmila Dissanaike, Jayne McCauley, Carlo Alphonso

Abstract

Donor site pain associated with skin graft procedures is frequently intense and difficult to treat. Liposomal bupivacaine, a prolonged-release local anesthetic indicated for single-dose administration to produce postsurgical analgesia, may be a viable option in managing donor site pain.

Keywords: Acute pain; analgesia; burns; pain; postoperative; skin transplantation.

Figures

Figure 1
Figure 1
Administration of liposomal bupivacaine into a thigh donor site prior to harvesting for split‐thickness skin grafting. Photograph courtesy of Sharmila Dissanaike, MD, FACS, and Jayne McCauley, MD.

References

    1. Bittner, E. A. , Shank E., Woodson L., and Martyn J. A.. 2015. Acute and perioperative care of the burn‐injured patient. Anesthesiology 122:448–464.
    1. Harbin, K. R. , and Norris T. E.. 2012. Anesthetic management of patients with major burn injury. AANA J. 80:430–439.
    1. Hernandez, J. L. , Savetamal A., Crombie R. E., Cholewczynski W., Atweh N., Possenti P., et al. 2013. Use of continuous local anesthetic infusion in the management of postoperative split‐thickness skin graft donor site pain. J. Burn Care Res. 34:e257–e262.
    1. Esfahlan, A. J. , Lotfi M., Zamanzadeh V., and Babapuor J.. 2010. Burn pain and patients’ responses. Burns 36:1129–1133.
    1. Anderson, T. A. , and Fuzaylov G.. 2014. Perioperative anesthesia management of the burn patient. Surg. Clin. North Am. 94:851–861.
    1. Jellish, W. S. , Gamelli R. L., Furry P. A., McGill V. L., and Fluder E. M.. 1999. Effect of topical local anesthetic application to skin harvest sites for pain management in burn patients undergoing skin‐grafting procedures. Ann. Surg. 229:115–120.
    1. Mendoza, A. , Santoyo F. L., Agullo A., Fenandez‐Canamaque J. L., and Vivo C.. 2016. The management of pain associated with wound care in severe burn patients in Spain. Int. J. Burns Trauma. 6:1–10.
    1. Richardson, P. , and Mustard L.. 2009. The management of pain in the burns unit. Burns 35:921–936.
    1. Redan, J. A. , Wells T., Reeder S., and McCarus S. D.. 2016. Reducing opioid adverse events: a safe way to improve outcomes. Surg. Technol. Int. 28:101–109.
    1. Jarzyna, D. , Jungquist C. R., Pasero C., Willens J. S., Nisbet A., Oakes L., et al. 2011. American Society for Pain Management Nursing guidelines on monitoring for opioid‐induced sedation and respiratory depression. Pain Manag. Nurs. 12:118–145.
    1. Barletta, J. F. 2012. Clinical and economic burden of opioid use for postsurgical pain: focus on ventilatory impairment and ileus. Pharmacotherapy 32(9 Pt 2):12S–18S.
    1. Benyamin, R. , Trescot A. M., Datta S., Buenaventura R., Adlaka R., Sehgal N., et al. 2008. Opioid complications and side effects. Pain Physician 11(2 Suppl):S105–S120.
    1. Golembiewski, J. , and Dasta J.. 2015. Evolving role of local anesthetics in managing postsurgical analgesia. Clin. Ther. 37:1354–1371.
    1. Exparel . 2016. Prescribing information. Pacira Pharmaceuticals, Inc., Parsippany, NJ.
    1. Bergese, S. D. , Ramamoorthy S., Patou G., Bramlett K., Gorfine S. R., and Candiotti K. A.. 2012. Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia. J. Pain Res. 5:107–116.
    1. Dasta, J. , Ramamoorthy S., Patou G., and Sinatra R.. 2012. Bupivacaine liposome injectable suspension compared with bupivacaine HCl for the reduction of opioid burden in the postsurgical setting. Curr. Med. Res. Opin. 28:1609–1615.
    1. McCauley, J. , Elshiekh M., Kesey J., and Dissanaike S.. 2016. Liposomal bupivacaine injection significantly reduces or eliminates donor site pain in burn surgery [abstract 414]. J. Burn Care Res. 37(suppl):S274.
    1. Alphonso, C. , Leazer S., and Bitner D.. 2016. Liposomal bupivacaine for postoperative analgesia in burn donor sites: a case series report [abstract 179]. J. Burn Care Res. 37(suppl):S156.
    1. Alphonso, C. , and Leazer S.. 2016. Liposomal bupivacaine case series: a novel approach to donor site pain [poster]. Presented at: Annual Meeting of the American Burn Association; May 3‐6, 2016; Las Vegas, NV.
    1. Hadzic, A. , Abikhaled J. A., and Harmon W. J.. 2015. Impact of volume expansion on the efficacy and pharmacokinetics of liposome bupivacaine. Local Reg Anesth. 8:105–111.
    1. Centers for Medicare & Medicaid Services . Opioid oral morphine milligram equivalent (MME) conversion factors. Available at: (accessed September 19, 2017).
    1. Ferreira‐Valente, M. A. , Pais‐Ribeiro J. L., and Jensen M. P.. 2011. Validity of four pain intensity rating scales. Pain 152:2399–2404.
    1. Buckenmaier 3rd, C. C. , Galloway K. T., Polomano R. C., McDuffie M., Kwon N., and Gallagher R. M.. 2013. Preliminary validation of the Defense and Veterans Pain Rating Scale (DVPRS) in a military population. Pain Med. 14:110–123.
    1. Polomano, R. C. , Galloway K. T., Kent M. L., Brandon‐Edwards H., Kwon K. N., Morales C., et al. 2016. Psychometric testing of the Defense and Veterans Pain Rating Scale (DVPRS): a new pain scale for military population. Pain Med. 17:1505–1519.
    1. Myers, R. , Lozenski J., Wyatt M., Pena M., Northrop K., Bhavsar D., et al. 2017. Sedation and analgesia for dressing change: a survey of American Burn Association Burn Centers. J. Burn Care Res. 38:e48–e54.
    1. Desai, C. , Wood F. M., Schug S. A., Parsons R. W., Fridlender C., and Sunderland V. B.. 2014. Effectiveness of a topical local anaesthetic spray as analgesia for dressing changes: a double‐blinded randomised pilot trial comparing an emulsion with an aqueous lidocaine formulation. Burns 40:106–112.
    1. Wasiak, J. , Spinks A., Costello V., Ferraro F., Paul E., Konstantatos A., et al. 2011. Adjuvant use of intravenous lidocaine for procedural burn pain relief: a randomized double‐blind, placebo‐controlled, cross‐over trial. Burns 37:951–957.
    1. Cuignet, O. , Mbuyamba J., and Pirson J.. 2005. The long‐term analgesic efficacy of a single‐shot fascia iliaca compartment block in burn patients undergoing skin‐grafting procedures. J. Burn Care Rehabil. 26:409–415.
    1. Fuzaylov, G. , Kelly T. L., Bline C., Dunaev A., Dylewski M. L., and Driscoll D. N.. 2015. Post‐operative pain control for burn reconstructive surgery in a resource‐restricted country with subcutaneous infusion of local anesthetics through a soaker catheter to the surgical site: preliminary results. Burns 41:1811–1815.
    1. Ilfeld, B. M. 2017. Continuous peripheral nerve blocks: an update of the published evidence and comparison with novel, alternative analgesic modalities. Anest. Analg. 124:308–335.
    1. Ilfeld, B. M. 2011. Continuous peripheral nerve blocks: a review of the published evidence. Anesth. Analg. 113:904–925.
    1. Viscusi, E. R. 2015. The safety of liposome bupivacaine 2 years post‐launch: a look back and a look forward. Expert Opin. Drug Saf. 14:1801–1803.
    1. Hu, D. , Onel E., Singla N., Kramer W. G., and Hadzic A.. 2013. Pharmacokinetic profile of liposome bupivacaine injection following a single administration at the surgical site. Clin. Drug Invest. 33:109–115.
    1. Bergese, S. D. , Onel E., Morren M., and Morganroth J.. 2012. Bupivacaine extended‐release liposome injection exhibits a favorable cardiac safety profile. Reg. Anesth. Pain Med. 37:145–151.
    1. Gadsden, J. , and Long W. J.. 2016. Time to analgesia onset and pharmacokinetics after separate and combined administration of liposome bupivacaine and bupivacaine HCl: considerations for clinicians. Open. Orthop. J. 10:94–104.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi